Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Liu Ze-yuan is active.

Publication


Featured researches published by Liu Ze-yuan.


Annals of the New York Academy of Sciences | 2004

Drug abuse in China.

Zhao Chengzheng; Liu Zhimin; Zhao Dong; Liu Yanhong; Liang Jianhui; Tang Yilang; Liu Ze-yuan; Zheng Jiwang

Abstract: The drug problem in China reappeared in the late 1980s. At that time, most drug abusers used opium only, with heroin accounting for a very small proportion and its use being limited to border areas in the southwest and rural areas in the northwest. Beginning in the early 1990s, drug abuse spread quickly. The number of registered drug addicts increased from 70,000 in 1990 to one million by the end of 2002. Besides opioids, some “new” kinds of drugs including amphetamines and ketamine have penetrated the country through various channels since 1997. Drug abuse has caused severe problems for both the abusers and society. Three types of treatment settings for detoxification and rehabilitation are available: compulsory detoxification institutions, rehabilitation units through labor, and voluntary detoxification institutions run by sections of public security, justice, and health, respectively. Medical treatment is often combined with psychological counseling and physical training. Pharmaceutical therapy, traditional Chinese medicine, and nonpharmaceutical therapy are utilized for opioid addiction. Drug prevention, especially for young people, is emphasized. NGOs at different levels have all joined in this work. Intervention work was also started in regions where drug abuse and HIV/AIDS problems are serious. Drug abusers are helped to keep drug free after being released from detoxification settings by their communities. Different levels of institutions engaged in research on drug abuse are found in all parts of China.


Chinese Pharmacological Bulletin | 2011

Reversing mechanism of schizandrin A on multi-drug resistance of K562/ADR,HL60/ADR,MCF-7/ADR cell lines

Liu Ze-yuan


Zhongnan Yaoxue | 2016

健常者におけるアーテスネートの生物学的同等性の研究【JST・京大機械翻訳】

Wang Xiaofang; Hao Guangtao; Zhang Yuanyuan; Gao Hongzhi; Liu Ze-yuan; Dong Ruihua; Li Yuanyuan; Liu Feifei; Tian Fang; Zhang Nan; Dai Bing; Qu Hengyan


Zhongguo Linchuang Yaolixue Zazhi | 2016

腎細胞癌の治療におけるスニチニブの副作用とその一塩基多型と血中濃度の関連性に関する研究の現状【JST・京大機械翻訳】

Zhang Yuanyuan; Bi Guofang; Liu Ze-yuan; Qu Hengyan


Zhongguo Linchuang Yaolixue Zazhi | 2016

ヒト血漿中のエストラジオールの含有量を,液体クロマトグラフィータンデム質量分析を測定した。【JST・京大機械翻訳】

Cheng Longmei; Hao Guangtao; Chen Xueyi; Zhang Yingfu; Dong Ruihua; Liu Ze-yuan; Qu Hengyan


Zhongguo Linchuang Yaolixue Zazhi | 2016

ヒト血漿中の克Zuo替尼の濃度を高速液体クロマトグラフィー-質量分析法により測定した。【JST・京大機械翻訳】

Bi Guofang; Hao Guangtao; Chen Xueyi; Zhang Yingfu; Zhang Yuanyuan; Dai Hanlu; Cheng Longmei; Liu Ze-yuan; Qu Hengyan


The Chinese Journal of Clinical Pharmacology | 2016

Determination of crizotinib in human plasma by HPLC-MS/MS

Bi Guofang; Hao Guangtao; Chen Xueyi; Zhang Yingfu; Zhang Yuanyuan; Dai Hanlu; Cheng Longmei; Liu Ze-yuan; Qu Hengyan


The Chinese Journal of Clinical Pharmacology | 2013

Bioequivalence of metformin in healthy volunteers by HPLC-MS/MS

Liu Ze-yuan


Chinese Journal of Pharmaceutical Analysis | 2013

HPLC-MS/MS determination of 5-fluorouracil in human plasma

Liu Ze-yuan


The Chinese Journal of Clinical Pharmacology | 2012

Analysis of tigecycline therapy in patient with pan drug resistant Acinetobacter baumannii

Liu Ze-yuan

Collaboration


Dive into the Liu Ze-yuan's collaboration.

Top Co-Authors

Avatar

Hao Guangtao

Academy of Military Medical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tang Yilang

Capital Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge